Bard Financial Services Inc. Has $8.14 Million Stock Position in CVS Health Corporation $CVS

Bard Financial Services Inc. cut its stake in shares of CVS Health Corporation (NYSE:CVS) by 7.3% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 107,988 shares of the pharmacy operator’s stock after selling 8,490 shares during the quarter. Bard Financial Services Inc.’s holdings in CVS Health were worth $8,141,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CVS. Symmetry Partners LLC increased its holdings in CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock worth $439,000 after purchasing an additional 141 shares in the last quarter. Harbor Capital Advisors Inc. boosted its position in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. HF Advisory Group LLC raised its stake in CVS Health by 2.9% during the 3rd quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock worth $393,000 after buying an additional 145 shares during the period. FineMark National Bank & Trust boosted its holdings in CVS Health by 1.7% in the second quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock worth $661,000 after acquiring an additional 157 shares in the last quarter. Finally, 1620 Investment Advisors Inc. grew its stake in CVS Health by 6.1% in the third quarter. 1620 Investment Advisors Inc. now owns 2,736 shares of the pharmacy operator’s stock valued at $206,000 after acquiring an additional 157 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Argus increased their target price on CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Leerink Partners lifted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 16th. The Goldman Sachs Group upped their target price on shares of CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, December 10th. Finally, Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.67.

CVS Health Stock Performance

NYSE CVS opened at $79.60 on Friday. The company’s 50 day moving average is $78.91 and its 200-day moving average is $72.96. The firm has a market cap of $101.04 billion, a P/E ratio of 209.47, a price-to-earnings-growth ratio of 0.79 and a beta of 0.48. CVS Health Corporation has a 12-month low of $43.65 and a 12-month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.